World Heart Corp. (WHRT)

[DonShimoda]

Wedbush says Medicare decision positive for ventricular device makers

In a note to investors, Wedbush analysts Dr. Duane Nash and Akiva Felt wrote that weakness in providers of left ventricular assist devices - including Thoratec (THOR), HeartWare (HTWR), and WorldHeart (WHRT) - could create an attractive entry point for investors.

Wedbush notes that the CMS said last night it is not expanding left ventricular assist device, or LVAD, reimbursement to include to Class IIIB patients. However, the firm points out CMS did make positive changes to the objective criteria. Wedbush recommends using any weakness in shares of Thoratec (THOR), HeartWare (HTWR), and World Heart (WHTR) following the news as buying opportunities.